News & Events about Sensei Biotherapeutics Inc.
Sensei Biotherapeutics, Inc. (NASDAQ:SNSE Get Rating)s stock price traded down 16.6% during mid-day trading on Friday . The stock traded as low as $1.47 and last traded at $1.51. 191,004 shares were traded during trading, an increase of 165% from the average session volume of 72,001 shares. The ...
Ticker Report
2 months ago
Sensei Biotherapeutics (NASDAQ:SNSE Get Rating) and Design Therapeutics (NASDAQ:DSGN Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, risk, profitability...
Globe Newswire
3 months ago
BOSTON, March 06, 2023 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), an immuno-oncology company focused on the discovery and development of next generation therapeutics for cancer patients, today announced that Company management will present at Oppenheimers 33rd Annual Healthcare...
Globe Newswire
3 months ago
BOSTON, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), an immuno-oncology company focused on the discovery and development of next generation therapeutics for cancer patients, today announced that Company management will participate in a fireside chat at Citis 2023 ...
Globe Newswire
3 months ago
BOSTON, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients, will present new preclinical data on SNS-101, a conditionally active, pH-selective VISTA-...